Literature DB >> 35553293

Characterization of EPO H131S as a key mutation site in the hypoxia-adaptive evolution of Gymnocypris dobula.

Congcong Wang1,2,3,4,5, Qin Zhang6, Yang Liu6,7,8,9, Qianghua Xu10,11,12,13,14.   

Abstract

Erythropoietin (EPO) is a glycoprotein hormone involved in proerythropoiesis, antioxidation, and antiapoptosis. It also contributes to cellular immune function in high-altitude species, such as the schizothoracine fish Gymnocypris dobula. Six mutation sites previously identified in EPO from G. dobula (GD-EPO) were injected into zebrafish embryos, and their effects were compared with EPO from the low-altitude schizothoracine Schizothorax prenanti. The key mutation site in GD-EPO was identified as H131S. Under hypoxic conditions, the levels of superoxide dismutase and malondialdehyde were decreased, whereas that of nitric oxide was increased in zebrafish injected with GD-EPO compared with those injected with S. prenanti-EPO (SP-EPO). The results suggest that EPO in high-altitude schizothoracine species is both antioxidative and antiapoptotic, driven by the H131S mutation site. Thus, this enhanced the ability of this species to adapt to the high-altitude hypoxic environment. These results provide a basis for investigating further the hypoxia adaptation mechanisms of teleosts.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Antiapoptosis; Antioxidation; EPO; Gymnocypris dobula; H131S

Mesh:

Substances:

Year:  2022        PMID: 35553293     DOI: 10.1007/s10695-022-01080-6

Source DB:  PubMed          Journal:  Fish Physiol Biochem        ISSN: 0920-1742            Impact factor:   2.794


  41 in total

Review 1.  Nitric oxide in adaptation to altitude.

Authors:  Cynthia M Beall; Daniel Laskowski; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2012-01-20       Impact factor: 7.376

2.  Two routes to functional adaptation: Tibetan and Andean high-altitude natives.

Authors:  Cynthia M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

3.  Inhibition of Bax channel-forming activity by Bcl-2.

Authors:  B Antonsson; F Conti; A Ciavatta; S Montessuit; S Lewis; I Martinou; L Bernasconi; A Bernard; J J Mermod; G Mazzei; K Maundrell; F Gambale; R Sadoul; J C Martinou
Journal:  Science       Date:  1997-07-18       Impact factor: 47.728

4.  Erythropoietin: gene cloning, protein structure, and biological properties.

Authors:  J K Browne; A M Cohen; J C Egrie; P H Lai; F K Lin; T Strickland; E Watson; N Stebbing
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1986

5.  Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells.

Authors:  J M Davis; T Arakawa; T W Strickland; D A Yphantis
Journal:  Biochemistry       Date:  1987-05-05       Impact factor: 3.162

6.  Oxidative stress and apotosis to zebrafish (Danio rerio) embryos exposed to perfluorooctane sulfonate (PFOS) and ZnO nanoparticles.

Authors:  Jia Du; Jun Cai; Shutao Wang; Hong You
Journal:  Int J Occup Med Environ Health       Date:  2017-03-17       Impact factor: 1.843

Review 7.  Nitric oxide and cancer: a review.

Authors:  Sheetal Korde Choudhari; Minal Chaudhary; Sachin Bagde; Amol R Gadbail; Vaishali Joshi
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

8.  The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.

Authors:  Z Chen-Levy; J Nourse; M L Cleary
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 9.  Antioxidants, oxidative damage and oxygen deprivation stress: a review.

Authors:  Olga Blokhina; Eija Virolainen; Kurt V Fagerstedt
Journal:  Ann Bot       Date:  2003-01       Impact factor: 4.357

10.  Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury.

Authors:  Jonas Blixt; Eli Gunnarson; Michael Wanecek
Journal:  J Neurotrauma       Date:  2018-01-11       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.